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Abstract: Nail changes are present in about 50% of psoriasis patients and tend to be refractory to conventional treatments. 
Pulsed dye laser has emerged as an alternative therapy. Our aim is to evaluate the efficacy of pulsed dye laser in nail psoriasis 
and the impact of treatment on quality of life. Fourteen patients were treated in monthly sessions for three months. The outcome 
assesment was made by the Nail Psoriasis Severity Index (NAPSI). The median improvement in the scores of the overall NAPSI, 
nail bed NAPSI, and nail matrix NAPSI were 44.2% (P = 0.002), 50% (P = 0.033) and 65.1% (P = 0.024), respectively.
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Psoriasis is a chronic inflammatory disease with a 2% prev-
alence in the world population. Nail changes are present in approx-
imately 50% of these patients and may affect up to 80% of them at 
some time during their lives.1 Even the mild forms of the disease 
have a negative impact on oexcluir quality of life.2
Nail psoriasis (NP) is noted for being resistant to treatment.3 
Only 19.3% of the patients show significant improvement with the 
use of any topical treatment, and 77% of them would like to under-
go a more effective treatment.2
Pulsed dye laser (PDL) has emerged as a therapeutic alter-
native for NP and has been established as a therapeutic choice for 
treating plaque psoriasis.4
This clinical trial was performed to assess the effectiveness 
of PDL in treating NP. The sample was calculated in 12 patients. To 
participate in this study, the patients could not have used systemic 
treatment or undergone phototherapy for at least eight weeks prior 
to the study, nor could they have undergone topical treatment for 
two weeks prior to the study or display onychomycosis or any other 
concomitant nail diseases. 
Three PDL (Candela Vbeam Perfecta®, 595 nm pulsed dye 
laser) sessions were applied in four-week intervals, using the same 
application parameters for all participants: spot size 7 mm, pulse 
duration 0.45 ms, fluence 6J/cm².
Three clinical assessments were performed: before the first 
session, in the third session, and 90 days after the treatment had 
ended. In each assessment, the NAPSI, a score that objectively as-
sesses the intensity of nail impairment, was calculated. In addition, 
patients answered the DLQI (Dermatology Life Quality Index) 
questionnaire before and after treatment and, in their last appoint-
ment, answered a treatment assessment questionnaire.
Fourteen patients participated in the study. The mean age 
± standard deviation was 44.1 ± 16.4 years, and they had had nail 
changes for 7.2 ± 6.49 years.
There was a significant reduction in NAPSI in follow-up 
(three months after the last session) compared to basal (P = 0.002) 
(Figure 1). The median (percentile 25 and percentile 75) improve-
ment was 44.16% (7.08 and 65.63%) (Table 1). An improvement was 
also detected in the analysis of the nail bed NAPSI (P = 0.033). The 
median (p25 and p75) was 50% (1.67 and 73.86%).
Nail matrix changes were detected in ten of the 14 patients. 
The nail matrix NAPSI also revealed improvement if compared to 
the basal score (P = 0.024), with a median (p25 and p75) of 65.13% 
(24.36 and 89.29%). Among these patients, four reached NAPSI75 
(an improvement of at least 75% in the score), and two of the pa-
tients’ symptoms were resolved.
Received on 11.04.2016.
Approved by the Advisory Board and accepted for publication on 17.02.2017.
* Work performed at the University Hospital at the Federal University of Rio Grande do Sul (HCPA- UFRGS), Porto Alegre, RS, Brazil.
 Financial support: Fundo de Incentivo à Pesquisa e Eventos (FIPE/HCPA).
 Conflict of interest: none.
1 Graduate Program in Surgery - School of Medicine at the Federal University of Rio Grande do Sul – Porto Alegre (RS), Brazil.
2 Private practice – Porto Alegre (RS), Brazil.
3 Dermatology Service, Porto Alegre University Hospital at the Federal University of Rio Grande do Sul (HCPA-UFRGS) – Porto Alegre (RS), Brazil.
  ©2017 by Anais Brasileiros de Dermatologia
The pre-treatment DLQI median (p25 and p75) was 2.5 (1.0 
and 11.5). The post-treatment DLQI median was 1 (0.8 and 3.5). The 
index improvement median was 40% (P = 0.007).
All patients mentioned having light pain during the laser 
application. Only one of them exhibited increased nail sensitivity 
that lasted longer than 24 hours.
Regarding the patients’ level of satisfaction with the treat-
ment, the median (p25 and p75) was 4 points (1.5 and 8.3). Eight pa-
tients (57.1%) reported having improvement with the treatment, and 
the improvement expectation was achieved for seven of the patients 
(50%). Thirteen patients (92.9%) would undergo the treatment again.









































Figure 1: Box plot charts with the NAPSI and DLQI scores throughout the treatment
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Table 1: Comparative table over time
Pre 3 sessions Post P
General 22 (12 -41) 20 (15 -36) 14 (6 -29) < 0.001
Matrix 9 (0 -29) 5 (0 -25) 2 (0 -12) 0.001
Bed 12 (10 -20) 14 (8 -17) 5 (2 -17) 0.011
Data presented by the median (P25-P75) and compared by the Friedman test.
One of the the first changes noticed in NP is the increase in 
papillary dermis vasculature.4 Selective removal of abnormal vascu-
lature by PDL based on selective photodermolisis may be beneficial 
to the treatment.5 In addition, PDL reduces the number of T-lym-
phocytes on the skin, helping to control inflammation.6 Given that 
this method is not practical and its cost is high, it has been suggested 
as an alternative treatment for localized lesions that are refractory 
to usual treatment, as well as for those in which systemic treatment 
would not be warranted.7
Some studies used PDL in NP showing improvement in 
NAPSI score at the end of the treatment.1,8,9,10 This study’s results 
corroborate the results in the literature: seven (50%) patients reached 
NAPSI 50, while three (21.4%) reached NAPSI 75 at the end of the 
treatment. No patient presented the resolution of changes in all of 
the nails, which is consistent with the findings of Treewittayapoom 
et al.3, demonstrating an early response trend in matrix changes, 
when compared to those on the nail bed.
There is no consensus regarding the parameters to be used 
in the applications. Patients whose nails were subjected to energy 
with longer pulse duration reported a higher level of pain.3 We 
prefered the use of medium energy with lower pulse duration was 
preferred in order to cause an energy peak, increasing the chance of 
immediate vessel thrombosis, in addition to testing the efficacy of 
these parameters.
Despite a significant reduction in the NAPSI score, the im-
provement in nail aspects was only noticed by a little over half of the 
patients (57.1%), which may mean that the change was not as obvi-
ous or did not meet the patients’ expectations.10 This also explains 
the fact that there have not been significant changes in DLQI results.
Regarding this study’s limitations, the follow-up time could 
have been longer to allow for an assessment that would determine 
whether or not the observed response would be supported. More-
over, the use of a higher number of patients, and the existence of a 
control group, would increase the statistical power of the findings.
Given that there is no consensus, more studies are warrant-
ed to define the best application parameters. In addition, longer 
follow-up and treatment times could reveal results that are more 
striking. The observed results, however, allow one to consider the 
PDL to be a promising therapeutic modality, as it leads to clinical 
improvement, as well as to the improvement in the patient quality 
of life, in addition to presenting good application tolerability. q
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